Voyageur Pharmaceuticals Ltd VM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CA$0.14
- Day Range
- CA$0.14–0.14
- 52-Week Range
- CA$0.07–0.20
- Bid/Ask
- CA$0.13 / CA$0.14
- Shares Outstanding
- 226.34M
- Market Cap
- CA$31.69M
- Volume/Avg
- 112,000 / 150,031
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 501.86
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Voyageur Pharmaceuticals Ltd is a Canadian development-stage pharmaceutical company developing and selling barium and iodine active pharmaceutical ingredients (API) and high-performance, cost-effective imaging contrast agents for medical radiology. Its product portfolio comprises SmoothX (a barium sulfate suspension), SmoothHD, SmoothLD (a low-density barium suspension solution), VisionHD (a high-density barium powder suspension), VisionLD, V-Gas, and others. Additionally, the company has interests in two mineral properties: Frances Creek and Jubilee Mountain, located in the province of British Columbia, Canada, and the ULI Project in the state of Utah, United States of America.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- —
Valuation
|
Metric
|
VM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 59.37 |
Price/Sales | 501.86 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
VM
|
|---|---|
Quick Ratio | 0.18 |
Current Ratio | 0.23 |
Interest Coverage | — |
Quick Ratio
VM
Profitability
|
Metric
|
VM
|
|---|---|
Return on Assets (Normalized) | −84.85% |
Return on Equity (Normalized) | −288.40% |
Return on Invested Capital (Normalized) | −276.57% |
Return on Assets
VM
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|knRj$G#F | LOCK|Hb$Ph | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|J@$z^$R | LOCK|@R%# | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|$>Dhq!g | LOCK|^$y | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|q?%ZN!N | LOCK|f$ | $29B | |||
| Viatris Inc
VTRS
| LOCK|!>rh?sQ | LOCK|k&z | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|VMg | LOCK|wvv | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|WF$vPY | LOCK|>! | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|H$x&%> | LOCK|h!Z | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|HWG^g> | LOCK|rS^! | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|&hRqT?^ | LOCK|T<% | $2B |
United States